Cosmetic use of BTX has skyrocketed in recent years, especially since the approval of BTX-A for treatment of glabellar lines. Complications and adverse reactions can easily arise, particularly for the novice injector. This paper provides insights from an experienced physician on how to avoid these complications, and how to treat them when and if they occur. The main cosmetic uses for BTX are analyzed for possible complications and adverse events. Injection techniques are discussed. Comparisons between BTX-A and BTX-B are given to point out the need for different injection techniques based on the product being used. Treatment recommendations for the Glabella, Brow, Crow's Feet, Upper Lip Wrinkling/Lines, Depressor Anguli Oris, Nasolabial Folds, Mentalis, Neck and Hyperhidrosis are discussed, as well as systemic complications. It is important for the injecting physician to be familiar with these potential complications, even though the use of BTX has been safe and generally well tolerated, because it will lead to even greater success with the use of BTX.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clindermatol.2003.12.026 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Meta-Analysis of Adverse Reactions of Botulinum Toxin A in Facial Rejuvenation Treatment.
Aesthetic Plast Surg
December 2024
Burn, Plastic and Wound Repair Surgery, Longyan First Affiliated Hospital of Fujian Medical University, No.105, Jiuyi North Road, Zhongcheng Street, Xinluo District, Longyan, 364000, Fujian Province, China.
Background: Facial rejuvenation is a popular non-surgical treatment, and its treatment safety is of key significance to patients. The purpose of this meta-analysis is to compare the effects of botulinum toxin A and placebo on the occurrence of adverse reactions in facial rejuvenation treatment.
Objective: According to PRISMA guidelines, a comprehensive search was conducted in Chinese and English databases, and 20 randomized controlled trials (RCTs) were included.
Melasma Management: A Comprehensive Review of Treatment Strategies Including BTX-A.
J Cosmet Dermatol
November 2024
Skin Laser & Surgery Specialists, A Division of Schweiger Dermatology Group, New York, New York, USA.
Background: Botulinum toxin A (BTX-A) is a widely utilized protein derived from the bacterium Clostridium botulinum, known for its effectiveness in treating various medical conditions involving muscle spasticity, involuntary muscle movements, and pain disorders. Beyond its therapeutic applications, BTX-A is also commonly used in cosmetic procedures to address dynamic wrinkles, hyperhidrosis, sebum production, pore size, and overall skin texture. While the use of neurotoxins like BTX-A for treating conditions such as UVB-induced hyperpigmentation, specifically melasma, is an emerging area of interest, it is not yet a widely recognized treatment for this dermatologic condition.
View Article and Find Full Text PDFWe evaluated real-life experiences of a topical neuro-peptide serum containing 2% acetyl hexapeptide-8, 2% dipeptide diaminobutyroyl, 5% polyhydroxy acids (PHA), 5% niacinamide, and 1% laminaria extract (topical neuro-peptide serum [TNP-serum]). The TNP-serum works synergistically by stimulating 9 key skin biomarkers to reduce wrinkles and produce a skin-brightening effect. Here, we highlight the real-life experiences of 5 dermatologists and 2 surgeons, using an integrated skincare regimen consisting of botulinum toxin type-A (BTX-A) injection in conjunction with twice daily TNP-serum.
View Article and Find Full Text PDF[Research progress of botulinum toxin A in the therapeutic applications of oral diseases].
Zhonghua Kou Qiang Yi Xue Za Zhi
November 2024
Department of Stomatology, The First Affiliated Hospital of Zhejiang University School of Medicine, School of Stomatology, and Key Laboratory of Oral Biomedical Research of Zhejiang Province, Hangzhou310003, China.
Botulinum toxin A (BTX-A) is a powerful neurotoxin produced by Clostridium botulinum, which can relieve muscle spasm or limit gland secretion by inhibiting the release of acetylcholine at the neuromuscular/glandular junction. In addition, BTX-A can also play a role in the sensory feedback loop, which can ease pain. Currently, dentists are paying more attention to the cosmetic applications of BTX-A in the oral and maxillofacial region, while their understanding of BTX-A's non-cosmetic applications is still insufficient.
View Article and Find Full Text PDFReduced Injection Site Pain with Altered pH in 24-h Reconstituted Botulinum Toxin: Findings from a Randomized Controlled Study on Cosmetic Applications.
Aesthetic Plast Surg
October 2024
Department of Facial Plastic and Cranio-Maxillo-Facial Surgery, Fakih Hospital, Khaizaran, Lebanon.
Article Synopsis
- Botulinum toxin (BTX) injections, popular for cosmetic uses, often lead to injection site pain (ISP), prompting the need for better pain management strategies.
- This study focused on adjusting the pH levels of reconstituted BTX to see if it could reduce ISP, involving 24 volunteers who received both fresh and 24-hour reconstituted toxin on different sides of their faces.
- Results showed that the more acidic fresh toxin caused more pain (mean VAS score of 5.92) compared to the less acidic reconstituted toxin (mean VAS score of 4.17), suggesting that pH adjustments can help alleviate discomfort, although larger studies are needed for further validation.*
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!